About Ares Serono
Ares Serono is a Healthcare company based in Geneve (Switzerland) founded in 1997, and was acquired by Merck in September 2006. RD company focused on manufacturing of drugs for multiple therapeutic areas. Its focus areas include Pharmacies and Pharmaceutical Drugs.
Company details
Ares Serono was established in 1997 in Geneva, Switzerland, as an RD-focused entity in the pharmaceutical sector. Operations center on the development and manufacturing of drugs targeting various therapeutic areas, including reproductive health and neurology. The companys activities are supported by its domain, serono.com, and are conducted primarily from its Swiss base to serve global markets in biotechnology and healthcare.
- Headquarters Geneve, Switzerland
- Stage Acquired
- SectorsHealthcare
- Website serono.com
- Acquired by Merck (Sep 2006)
Investors in Ares Serono
Ares Serono has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merck.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Merck is engaged in science and technology solutions globally. | 1668 | merckgroup.com | Darmstadt, Germany |
Investor details for Ares Serono
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ares Serono
2 dated milestones of Ares Serono across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Ares Serono is founded.
- Exit Acquired by Merck.
Web traffic of Ares Serono
Websites that share an audience with Ares Serono (serono.com).
Websites whose visitors overlap most with Ares Serono. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| richter.hu | 100% | #2,272,079 | View details | ||
| merck.de | 97% | 12.3K | #973,850 | View details | |
| merckgroup.com | 90% | 910.8K | #54,804 | View details | |
msdchina.com.cn | msdchina.com.cn | 90% | #4,167,479 | – | |
richelet.fr | richelet.fr | 90% | #5,196,077 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Ares Serono
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ares Serono
Complete news archive for Ares Serono
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ares Serono
Ares Serono was founded in 1997.
Ares Serono is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Ares Serono was established in 1997 in Geneva, Switzerland, as an RD-focused entity in the pharmaceutical sector. Operations center on the development and manufacturing of drugs targeting various therapeutic areas, including reproductive health and neurology. The companys activities are supported by its domain, serono.com, and are conducted primarily from its Swiss base to serve global markets in biotechnology and healthcare.
Ares Serono has 1 investor. Key investors include Merck.
Yes. Ares Serono was acquired by Merck in September 2006.